Editorial: Endocrine complications of COVID-19: short and long

Editorial: Endocrine complications of COVID-19: short and long

Saved in:

Bibliographic Details
Main Author:	Kamyar Asadipooya
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-08-01
Series:	Frontiers in Endocrinology
Subjects:	ACE2 complication COVID-19 endocrine management
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2025.1668201/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Short- and long-term psychiatric complications of COVID-19
by: Gellan K. Ahmed, et al.
Published: (2025-05-01)

Abnormalities of Endocrine Function Tests in COVID-19-Recovered Individuals
by: Phibakordor L. Nonglait, et al.
Published: (2025-05-01)

COVID-19 and Cardiovascular System: Pathophysiology, Pathomorphology, Complications, Long-Term Prognosis
by: S. S. Petrikov, et al.
Published: (2021-04-01)

Evidence‐based management strategies for endocrine complications after pituitary adenoma surgery
by: Xiaoju Miao, et al.
Published: (2025-06-01)

Thyroid disorders and COVID-19: a comprehensive review of literature
by: Narges Anbardar, et al.
Published: (2025-05-01)

Oxidative Stress and Its Association with COVID-19: A Narrative Review
by: Hardi Rafat Baqi, et al.
Published: (2020-06-01)

ACE-2-like enzymatic activity in COVID-19 convalescents with persistent pulmonary symptoms associated with immunoglobulin
by: Yufeng Song, et al.
Published: (2025-08-01)

Relationship of ACE1 and ACE2 genetic polymorphisms on SARS-CoV-2 infection and severity of symptoms in different regions of Iraq
by: Bilal Ali Khashan, et al.
Published: (2024-02-01)

A comparative analysis of estrogen receptors, ACE2 and cytokines in pre-and postmenopausal women and men with COVID-19
by: Mélida Del Rosario Lizarazo-Taborda, et al.
Published: (2025-04-01)

Modulation of RAAS receptors and miRNAs in COVID-19: implications for disease severity, immune response, and potential therapeutic targets
by: Thais Freitas Barreto Fernandes, et al.
Published: (2025-03-01)

Corona Virus and Kidney Failure: A review
by: Zahraa Kareem Al-Mayali, et al.
Published: (2022-06-01)

Cardiovascular complications of COVID-19
by: I. A. Kozlov, et al.
Published: (2020-09-01)

Editorial: Cyclic nucleotide phosphodiesterases (PDEs) signaling in the endocrine system
by: Federica Campolo, et al.
Published: (2025-01-01)

Association between endocrine disrupting chemicals exposure and the risk of all-cause mortality in individuals with diabetes mellitus or its complications: A prospective cohort study
by: Yueheng Zhang, et al.
Published: (2025-06-01)

Skrining Potensi Essential Oil Cananga odorata dalam Penghambatannya Terhadap ACE II dan TMPRSS2 sebagai Anti Covid-19: Pendekatan In Silico
by: Yoni Rina Bintari, et al.
Published: (2023-01-01)

Impact of COVID-19 on the endocrine system
by: D. N. Zadumina, et al.
Published: (2023-04-01)

Clinical Impact of Neutrophil Variation on COVID-19 Complications
by: Khadija El Azhary, et al.
Published: (2025-02-01)

Effects of ABO Blood Groups and Helicobacter pylori on COVID-19 Susceptibility and Disease Severity: Findings from a Cross-Sectional Analysis
by: Maryam Nejabat, et al.
Published: (2025-03-01)

The I/D variant of the ACE gene affects the clinical characteristics of COVID-19 course in intensive care unit patients
by: Valeriy Pokhylko, et al.
Published: (2025-12-01)

RESIDUAL PHENOMENA OF THE TRANSFERRED COVID-19 IN THE MAXILLOFACIAL REGION OR ITS COMPLICATIONS
by: O.V. Rybalov, et al.
Published: (2021-06-01)

Humanized COVID‐19 decoy antibody effectively blocks viral entry and prevents SARS‐CoV‐2 infection
by: Kuo‐Yen Huang, et al.
Published: (2020-11-01)

Acute upper gastrointestinal mucosal lesions caused by COVID-19 infection: a case report
by: Ze Qi, et al.
Published: (2025-07-01)

The Effect of Nosocomial Infection on the Severity and Outcome of the Disease in Patients with Severe and Extremely Severe COVID-19
by: L. M. Kalmanson, et al.
Published: (2022-01-01)

Peripheral Nervous System Complications after COVID-19 Vaccination
by: Seyed Sepehr Khatami, et al.
Published: (2025-03-01)

A perspective of precision medicine in the management of COVID-19
by: Shrikant Verma, et al.
Published: (2021-08-01)

Editorial: Thyroid endocrine disruptors
by: Leonidas H. Duntas, et al.
Published: (2025-01-01)

Prevalence of face mask related complications among healthcare workers during the COVID-19 pandemic in Saudi Arabia
by: Khalifa Binkhamis, et al.
Published: (2024-02-01)

In Vitro Investigation of Statin Effects on Genes Associated with Severe COVID-19 in Cancerous and Non-Cancerous Cells
by: Adriana Kapustová, et al.
Published: (2025-07-01)

Editorial: Obesity and metabolism in endocrine-related cancers
by: Chiara Calabrese, et al.
Published: (2025-07-01)

Postoperative complications in patients infected with covid-19 (review of literature)
by: M. V. Timerbulatov, et al.
Published: (2021-06-01)

Double mutation for multiple endocrine neoplasia associated with congenital adrenal hyperplasia
by: Watrusy Lima de Oliveira, et al.
Published: (2025-06-01)

SARS‐CoV‐2 spike protein enhances MAP4K3/GLK‐induced ACE2 stability in COVID‐19
by: Huai‐Chia Chuang, et al.
Published: (2022-07-01)

Structural and Hormonal Changes in Reproductive-Age Women Post-COVID-19: A Cross-Sectional Ultrasound and Biochemical Study
by: Sandugash Yerkenova, et al.
Published: (2025-06-01)

A New <i>In Silico</i> Comparison of the Relative Affinity of Enantiomeric Chloroquine (CQ) and Hydroxychloroquine (HCQ) for ACE2
by: Carlos Naranjo-Castañeda, et al.
Published: (2025-06-01)

LONG-TERM OUTCOMES OF PATIENTS WITH COVID-19-RELATED ARDS WITH AND WITHOUT INITIAL COMORBIDITIES
by: М.V. OSIKOV¹,², et al.
Published: (2025-07-01)

Risk of venous thromboembolic complications in patients with diabetes mellitus and COVID-19
by: D. V. Abramov, et al.
Published: (2023-11-01)

Endothelial dysfunction in arterial hypertension - cardiovascular complication risk factor
by: B. A. Namakanov, et al.
Published: (2005-12-01)

Mental health trajectories over the COVID-19 pandemic among young adults reporting adverse childhood experiences
by: Behnam Mousavi, et al.
Published: (2025-07-01)

Endocrine Disorders Associated with Medicinal Products: Approaches to Preclinical Safety Assessment
by: K. L. Kryshen, et al.
Published: (2023-03-01)

Explore the Possibility of Early Clinical Diagnosis of Endocrine Ophthalmopathy Based on Eye Symptoms of Hyperthyroidism
by: V. G. Likhvantseva, et al.
Published: (2016-12-01)